|[February 04, 2014]
Girard Gibbs LLP Represents Children Allegedly Injured by Risperdal
SAN FRANCISCO --(Business Wire)--
Gibbs LLP is investigating claims on behalf of users of Risperdal
that the antipsychotic medication may be linked to the adverse side
effect of gynecomastia,
or male breast growth.
Hundreds of lawsuits have been filed alleging that Risperdal
manufacturer Janssen Pharmaceuticals, a subsidiary of Johnson & ohnson,
was aware of the risks associated with Risperdal use and intentionally
concealed these risks from parents and consumers. The lawsuits allege
that Risperdal causes irreversible breast growth in men and young boys
that may be accompanied by lactation.
For the parents of one Risperdal user, the struggle to manage symptoms
associated with autism was complicated by Risperdal's allegedly
undisclosed side effects. At age 8, their son had developed distinct
breasts. Seeking treatment for the gynecomastia proved increasingly
difficult as the child sought to hide the condition from others,
including his parents and medical providers.
"We are talking about a group of people, many of whom are young boys,
who are already suffering from the difficulties of behavioral and mental
health concerns," said Amy Zeman, a personal injury lawyer with Girard
Gibbs working directly with Risperdal clients. "Our clients turn to
Risperdal to help them, and instead end up in a situation where they are
facing breast reduction surgery and an incredibly difficult social and
emotional situation. I've spoken with mothers whose sons are too
embarrassed to discuss it even with their closest family members."
Consumers and parents of children affected by the use of Risperdal and
generic risperidone are encouraged to contact Girard Gibbs' Risperdal
attorneys to learn more about the investigation and explore their
potential claims for monetary compensation.
Girard Gibbs LLP has been distinguished by the U.S. News & World Report
as a Tier-1 law firm for plaintiffs' mass
tort and class action litigation. In addition to representing people
injured after taking Risperdal, Girard Gibbs represents plaintiffs
involving Fresenius dialysate products GranuFlo and Naturalyte; Yaz,
Yasmin, and Ocella birth control pills; the diabetes drug Actos;
transvaginal mesh implants; Eon spinal cord stimulators; the DaVinci
surgical robot; the Mirena IUD; and the blood-thinner Pradaxa.
[ Back To Technology News's Homepage ]